Veronica Soloveva

Veronica Soloveva is a Principal Scientist in High Content Imaging at Merck, where they lead efforts to enhance imaging capabilities within the Quantitative Biosciences department. They previously held significant roles, including as a Principal Research Scientist II at Pfizer, where they supervised a team in cellular assay development, and as a lead investigator at the Hanry M. Jackson Foundation, where they established collaborations on anti-viral therapies. Veronica also served as the Director of the Center of Core Technologies at IP-Korea, managing several image-based platforms. They earned a Ph.D. in Biochemistry from the University of Illinois at Chicago and have extensive experience in drug discovery and assay development.